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Abstract
Purpose Wastewater treatment plant (WWTP) is regarded as a potential source for transmission of Clostridioides difficile from
urban areas into the surface water, through feces of human and animals. The aim of this study was to screen and characterize the
C. difficile bacteria in inlet and outlet wastewater of different WWTPs in Tehran, Iran.
Methods Totally, 72 samples were collected from three different WWTPs (inlet site and outlet sites) during a year. C. difficile
was isolated and characterized in terms of toxins, toxinotype, resistance profile and genes, and colonization factors using PCR.
Results One C. difficile toxinotype V was isolated from the outlet samples. The isolate was susceptible to vancomycin but
resistant to metronidazole, tetracycline, ciprofloxacin, and moxifloxacin using MIC Test Strips. The isolated C. difficile was
toxigenic (tcdA, tcdB, cdtA, cdtB positive and CPE positive) and had tcdC-A genotype. No mutations were found in fliC and fliD.
The slpA sequence type was 078 − 01. The C. difficile was positive for tetM, int, but negative for vanA, nim, and tndX genes.
Mutations were not observed in gyrA and gyrB genes.
Conclusions This study provided evidence of presence of a multidrug-resistant C. difficile toxinotype V in one of the municipal
WWTP. The transmission of such isolate to the environment and reuse of treated wastewater by human pose a threat to human
health and dissemination of antibiotic resistant bacteria which are untreatable.
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Introduction
Clostridioides difficile is a cause of hospital-associated
C. difficile infection (HA-CDI) or community- associated
C. difficile infection (CA-CDI). In recent years, more than
25% of CDI cases have been attributed to the community
source [1]. CA-CDI is diagnosed in individuals without any
risk factors for CDI and contact with health care settings. In
addition to asymptomatic carriers, environment, animals, and
food are implicated in transmission of CA-CDI to human [2].
Wastewater treatment plant (WWTP) is regarded as an impor-
tant potential source for transmission of enteric pathogens
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such as C. difficile, and viruses from urban areas into the
surface water through feces of human and animals [3]. As
hotspots that contain a wide variety of resistant bacteria,
WWTPs play an important role in dissemination of antibiotic
resistance genes (ARGs) via transposons or other mobile ge-
netic elements (MGEs) among bacteria [3]. Characterization
of resistant pathogen bacteria (such as C. difficile toxinotype
V) in the inlet and outlet of WWTPs as hotspots for exchange
of antibiotic resistant genes are of highly importance [4].
Release of treated wastewater to environments can lead to
the discharge of resistant pathogens and ARGs. It was dem-
onstrated that ARGs are not reduced in effluents compared
with influents of WWTPs, and indeed they are enriched in
the effluent [4].
In the last decades, metronidazole and vancomycin are
used for treatment of CDI. The genes encoding resistance to
metronidazole (nim) and vancomycin (vanA) are carried on
plasmid or chromosome and transposon 1546 (Tn1546), re-
spectively [5, 6]. The nim and vanA genes were previously
detected in wastewater and drinking water [5, 6]. The hyper-
virulent strains of C. difficile PCR-ribotype 078 (RT078 or
toxinotype V) and RT027 are resistant to tetracycline [7] and
fluoroquinolones, respectively, [8] that is an important con-
cern at treatment. The resistance to fluoroquinolones is due to
mutations in gyrA and gyrB genes and resistance to tetracy-
cline is due to tetM gene [7, 8].
Outbreaks of CDI have been associatedwith the emergence
of hypervirulent strains; RT078 (toxinotype V) and RT027
(toxinotype III) with increased mortality in Europe, North
America, and Asia [9]. The hypervirulent strains produce
higher amounts of toxins such as TcdA (enterotoxin), TcdB
(cytotoxin), and CdtA/B and have mutations in a putative
negative regulator (TcdC) of toxins. Also, these strains are
resistant to fluoroquinolones [10]. The colonization factors
such as slpA (surface layer protein), fliC (flagellum fragment),
filD (flagellum cap), cwp84, and cwp66 (cell wall proteins) are
also implicated in colonization, survival and pathogenicity of
C. difficile strains [11].
Considering the mentioned points, effluents of WWTP
have to be examined for contamination by harmful microbes
such as E. coli and Enterococci as microbial indicators [12].
Presence of C. difficile as a cholrine- rellisient spore-forming
bacterium has been rarely investigated in the contaminated
aquatic environments such as wastewaters [2, 9, 13–18]. The
possible contamination of WWTPs outlet with pathogenic
bacteria includingmultidrug-resistantC. difficile toxinotype
V can play a role in the development of severeCDI and cause
serious health problem by releasing the wastewater into the
environment, and reuse of treated wastewater by human
[14].
In this study, the inlet and outlet wastewater of three dif-
ferent municipal WWTPs in Tehran, Iran, was examined for
C. difficile existence in a year. Moreover, toxins, colonization
factors, resistance genes, and toxinotype of isolatedC. difficile
were identified.
Materials and methods
Sampling scheme and sample collection
A cross-sectional study was performed from inlets and out-
lets of three municipal WWTPs which were sampled in
Tehran during a year on a monthly basis, between
June 2016 and 2017. The location of each WWTP in
Tehran, capacity (m3/d), and population equivalent are in-
dicated in Table 1. Totally, 72 samples were collected from
three different WWTPs. The wastewater samples were tak-
en in sterile bottles during 12 sampling visits for each
WWTP. Sampling points were similar for three WWTPs.
In each visit, two samples of wastewater were taken from
each point (site) including inlets site before initial screening
(untreated) and outlets at the point of release (treated). Each
sample was collected in 500-ml sterile bottles. The collect-
ed samples were transported on ice to laboratory and pre-
served at 4 °C for a maximum of 1 day to be tested.
Isolation of C. difficile
For isolation of C. difficile, 100 ml of non-concentrated outlet
wastewater sample (1:1 and 1:10 dilutions in sterile physio-
logical saline) and 100 ml of non-concentrated inlet wastewa-
ter sample (1:100 and 1:1000 dilutions in sterile physiological
saline) were concentrated using the filtration method through
a cellulose membrane filter (FILTEP-BIO) with a 0.45 µm
pore size using a vacuum pump (Membran-Vakuumpumpe,
Germany). The filters were then enriched in 25 ml of
Clostridium difficileMoxalactam Norfloxacin (CDMN) broth
with 0.1% sodium taurocholate and incubated in an anaerobic
atmosphere using the Anoxomat jar system (MART
Microbiology B.V., the Netherlands) at 37 °C for 7–10 days
[2]. After incubation period, 2 ml of the enriched broth culture
(sediment) was added to 2 ml of absolute ethanol and incu-
bated for 1 hour at room temperature and then centrifuged at
4,000 rpm for 10 min. The supernatant was discarded and the
pellet (100 µl) was streaked on CDMN agar and incubated
anaerobically at 37 °C for 48–72 hours. After incubation, the
plates were checked for C. difficile colonies odor and mor-
phology. The suspected colonies with raised, grey-white and
opaque appearance were Gram-stained. Single colonies with
Gram-positive bacilli were sub-cultured onto Brucella Agar
supplemented with 5% sheep blood (BBA) plates and incu-
bated anaerobically for 48 hours at 37 °C. Then, colonies were
examined for L-proline aminopeptidase (C. diff PRO™ Kit)
[15]. Number of colonies as colony forming units (CFU) per
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100 µl was recorded. In order to examine the toxicity of the
isolate and evaluate the cytopathic effect (CPE), the cytotox-
icity assay was performed [19].
Antimicrobial susceptibility testing (AST)
AST was performed using MIC Test Strips (Liofelichem,
Italy) for vancomycin, metronidazole, tetracycline, and
fluoroquinolones (ciprofloxacin and moxifloxacin) [20, 21].
Concentration gradient of vancomycin, metronidazole, and
tetracycline ranged from 0.016 to 256 mg/L and of ciproflox-
acin and moxifloxacin ranged from 0.002 to 32 mg/L. Fresh
colonies (24-hour) were used for AST to prepare a suspension
with 1 McFarland turbidity standard. The plates were then
incubated in anaerobically at 37 °C for 48 hours. They were
checked at 24 hours and 48 hours.
Molecular characterization of C. difficile
DNA extraction was performed using Chelex100 (Sigma,
USA) on C. difficile grown on Brucella Agar supplemented
with 5% sheep blood [22]. Conserved genes including tpi,
gluD, cdd3, cdu2, and 16S rDNA were amplified as described
previously in order to identify the C. difficile [23–26]. The
identified C. difficile was examined for the presence of tcdA,
tcdB, cdtA/B and tcdC genes as previously described [23, 27]
and subsequently the tcdC PCR product was subjected to se-
quencing. Also, slpA, fliC, and fliD were amplified and se-
quenced for C. difficile as described previously [28–30]. The
isolate was examined for the presence of vanA, nim, tetM,
gyrA, and gyrB genes using PCR [31–34]. The genes int and
tndX were also amplified as indicators of Tn916-like and
Tn5397-like, respectively [35, 36]. Toxinotyping was per-




In the present study, three isolates were detected in inlet of
WWTPs located in East, West, and South using PCRs
targeting gluD and tpi genes, but these isolates did not gener-
ate amplicons for the other conserved genes. Out of 72
samples, one sample (1.38%) was found to contain
C. difficile by a combination of tests as Gram staining
(Gram-positive bacillus), L-prolin aminopeptidase-positive
but negative indole-negative reactions and PCR for five con-
served genes. This isolate was recovered from outlet of
WWTP located in west of Tehran. The number of colonies
was 60 CFU per 100 µl of cultured suspension on BBA.
Antibiotic susceptibilities and antibiotic-resistant
genes
The Minimum inhibitory concentration (MIC) (mg/L) using
MIC Test Strips for vancomycin, metronidazole, tetracycline,
ciprofloxacin, and moxifloxacin are shown in Fig. 1. With
respect to the mentioned resistance genes, the C. difficile iso-
late was positive for some of them (Fig. 2). The characteristics
of antibiotic resistance in C. difficile isolate are indicated in
Table 2.
Molecular characteristics
The C. difficile isolate contained tcdA, tcdB and, cdtA/B genes
and yielded 100% CPE. The toxigenic C. difficile belonged to
toxinotype V. The genotype of tcdCwas tcdC-Awith 11 point
mutation and one 39 bp deletion between 341 and 379 nucle-
otides, resulted in severe truncation of the TcdC protein. The
sequence of tcdC (718 bp) for the isolate from outlet is avail-
able in the Supplementary file. Using slpA sequence typing,
this isolate was typed as 078 − 01. Sequencing of fliC and fliD
genes of this isolate revealed that they had no mutation and
were identical to fliC and fliD genes of theC. difficile 630. The
nucleotide sequences of fliC, fliD slpA, and tcdC genes were
deposited in GenBank. The sequence length of fliC, fliD, and
slpA genes along with the Genbank accession numbers are
shown in Table 3.
The mutations of quinolone-resistance determining region
(QRDR) gyrA and gyrB genes leading to amino acid substitu-
tions in Thr82→ Ile and Thr82→Val of GyrA and Ser366→
Val, Ser416 → Ala, Ser366 → Ala, Asp426 → Asn, and
Asp426 → Val of GyrB, were not found in the isolate. The
nucleotide sequences of gyrA and gyrB genes were deposited
Table 1 Description of
wastewater treatment plants WWTP no. Location in Tehran Capacity (m
3/d) Population equivalent (PE) (Person)
1 East 600 7000
2 West 24,000 100,000
3 South 450,000 4,200,000
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in GenBank under the accession numbers of MH753335 and
MH753336, respectively.
Discussion
Only oneC. difficile isolate was recovered from three different
municipal WWTPs in one year between June 2016 and
June 2017. The Abiotic parameters such as the competition
among different species of bacteria and also the oxygen con-
centration might be responsible for the observed differences in
isolation rate of C. difficile from the WWTPs inlet vs.. the
outlet [38]. The study conducted by Nikaeen et al.., in central
Iran; Isfahan reported noC. difficile in inlet and outlet samples
or in raw sludge of activated sludge similar to our results [2].
The higher rate of C. difficile (13.6%) was observed in the
wastewater samples than we found but from the other samples
in WWTP (digested sludge). The discrepancy in the isolation
rate of C. difficilemight be partly related to the selected meth-
od or sampling sites of WWTPs; for instance we did the sam-
pling from the inlet and outlet of WWTPs whereas they took
the samples from several sites including raw sludge, digested
sludge, dewatered digested sludge, inlet of anaerobic pond,
outlet of anaerobic pond, outlet of facultative pond and outlet
of maturation pond. However, there are a few studies all over
the world that have focused on isolation of C. difficile from
WWTPs [2, 9, 13–18]. The incidence of C. difficile in waste-
water samples in different countries is very variable (Fig. 3).
The recovery of C. difficile from our samples was lower com-
pared to other studies, which could be due to the difference in
detection methods, selection of culture medium and/or sam-
pling sites. The differences in isolation rates of multiple studies
indicate that it is better to have a universal isolation method for
C. difficile detection from wastewater. There are reports from
Italy, France, andAustralia about the environmental dispersion
of Clostridiaceae via outlet of WWTPs between 2008 and
2010. These reports have focused on ability of spore detach-
ment from flocks of sludge into the outlet wastewaters
[39–41]. In our study, release of C. difficile into the outlet of
WWTP was observed that may provide a route for C. difficile
dissemination from WWTP to environment. It has been spec-
ulated that C. difficile strains or their spores, due to long-term
persistence can spread into the environment. In reality, it is
likely that C. difficile is a waterborne pathogen that can lead
to CDI in human when the contaminated water is consumed
[7]. In other words, the C. difficile spore formation (even in
very low levels [42]) provides a potential for wide dissemina-
tion and contamination of environment through wastewater
that are considered as an important transmission routes of
CDI [14].
In the current study, the C. difficile isolate from the outlet
was considered toxigenic according to positive results for PCR
of tcdA, tcdB, and cdtA/B genes and observation of a 100%
CPE on Vero cells after 24 hours. This finding is consistent
with the other studies showing the presence of toxigenic
C. difficile in aquatic environments [2, 43]. In another study,
Saif et al., isolated the C. difficile from treated water samples in
South Wales and reported that 84.6% of isolates were TcdA
positive [16]. The toxigenic C. difficile is associated to a spec-
trum of CDI ranging from asymptomatic colonization, self-
limiting and mild disease to severe one including
pseudomembranous colitis that is life-threatening, toxic
megacolon, sepsis and death [44]. The tcdC sequencing is
one of the indicators of the hypervirulent C. difficile strains
[45]. The sequence of tcdC gene obtained from our isolate
illustrated that the genotype was tcdC-A. Genotype tcdC-A
was observed in toxinotypes V and VI of C. difficile [46].
It was found that the isolated C. difficile in this study from
the outlet of a WWTP is multidrug-resistant (MDR) strain. It
was susceptible to vancomycin with theMIC of lower than the
Fig. 1 Minimum inhibitory concentration (MIC; mg/L) values of
different antibiotics against the isolated C. difficile. (a) Concentration
gradient of vancomycin, metronidazole, and tetracycline ranged from
0.016 to 256 mg/L. The MIC˃2 mg/L for vancomycin and
metronidazole and MIC ˃ 0.25 mg/L for tetracycline are considered
resistant (red color). The MIC ≤ 2 mg/L is considered susceptible (green
color). (b) Concentration gradient of ciprofloxacin and moxifloxacin
ranged from 0.002 to 32 mg/L. The MIC˃4 mg/L for ciprofloxacin and
moxifloxacin are considered resistant (red color)
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Table 2 Characteristics of
antibiotic resistance in
Clostriudm difficile isolate
Antibiotic Targt gene Sequence Length (bp) Resistant or Susceptible using
MIC Test Strips
Vancomycin vanA Not amplified* Susceptible
Metronidazole nim Not amplified* Resistant
Tetracycline tetM
int (indicator of Tn916-like)





Ciprofloxacin gyrA and gyrB 390 Resistant
Moxifloxacin gyrA and gyrB 390 Resistant
* Not amplified: PCR was done but the relevant fragment was not observed
Fig. 2 Agarose gel
electrophoresis of PCR products
for antibiotic resistance genes in
the Clostridium difficile isolate.
Lanes 1 to 3 show positive
control, Clostridium difficile
isolate fromWWTP, and negative
control, respectively. M lane
(DNA Ladder) depicts 100 base
pairs Ladder. (a) The isolate was
negative for vanA gene (1030 bp);
(b) The isolate was negative for
nim gene (458 bp); (c) The isolate
was positive for tetM gene
(1080 bp); (d) The isolate was
positive for gyrA gene (390 bp)
and (e) The isolate was positive
for gyrB gene (390 bp)
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breakpoint (2 mg/L), and was resistant to metronidazole,
fluoroquinolones, and tetracycline (Fig. 1). The resistance pat-
tern of this isolate was similar to that of clinical isolates re-
covered from patients suffered from CDI in Iran [47]. The
presence of C. difficile strains which exhibited high-level
multi-resistance to erythromycin, tetracycline, clindamycin,
and moxifloxacin and carried several ARGs including ermB,
fusA and tetM have been detected in surface waters [48]. The
vanA and nim genes were not found in the C. difficile isolate
(Fig. 2). Another ARG, tetM gene, was detected in the
C. difficile isolate and the possible transposon of tetM,
Tn916-like, was also detected using int gene PCR amplifica-
tion (Table 2). More than 75% of C. difficile RT078 isolates
(toxinotype V) were known as tetracycline-resistant in North
American and European countries [7]. With regard to
fluoroquinolones, several studies demonstrated that there is
an association between nucleotide substitutions of gyrA and
gyrB genes and resistance to fluoroquinolones [34, 49],
However, such nucleotide substitutions were not found in
theC. difficile isolate in this study. Since theC. difficile isolate
was resistant to fluoroquinolones, this finding indicates that
the other mechanisms may play a role in the resistance to
fluoroquinolone.
The colonization factors including SlpA, FliC, and FliD
proteins play a role in attachment ofC. difficile to the intestine
mucus layer [50]. The sequencing of slpA has been employed
to type C. difficile strains [51]. The slpAST (slpA sequence
type) of the isolate was 078 − 01. This type of slpA was pre-
viously observed in C. difficile RT078 with GenBank acces-
sion no. AB470267 [30]. The N-terminal and C-terminal re-
gions of FliC are responsible for polymerization and secretion
of flagella, while the central part is the antigenic part (surface-
exposed) in the filament of flagella. Variation in the sequence
of fliC may result in changes of flagella movement [29]. The
sequence of fliD gene is highly conserved [50]. Here, there
was no mutation in the sequences of fliC and fliD genes of the
C. difficile isolate (Table 3).
In this study, the CE-ribotyping profile of this isolate did
not correspond to any type of the previously known profiles in
the ECDC-Leeds-Leiden reference C. difficile strain dataset
(data not shown). However, toxinotyping revealed that this
C. difficile belonged to toxinotype V which was also observed
in 18.4% of the Iranian C. difficile isolates obtained from stool
specimens of patients suffered from CDI [52]. One study was
conducted in Iran in 2015 for detection of C. difficile in
WWTPs. In that study, C. difficile was detected in different
sites of wastewater treatment plants, but toxinotype and
ribotype were not reported [2]. Norman et al.., (2011) also
found toxinotype V in 84.5% of human wastewater
C. difficile isolates in Texas, USA [13]. Another study from
Slovenia showed 32 different ribotypes for C. difficile isolates
from wastewater that belonged to toxinotypes 0, I, IX, V, and





Table 3 The sequence length of
fliC, fliD, and slpA genes along
with the GenBank accession
numbers
Gene Associated protein Sequence length (bp) GenBank accession numbers
filC flagellum fragment 838 MH885485
fliD flagellum cap 1425 MH698447
SlpA Surface-layer protein 1005 MH473346
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XXIV [17]. Toxinotype V has not been considered as a major
cause of CDI in hospitals; however, it was suggested that the
rate of isolation of C. difficile toxinotype V from humans is
increasing [13].
Conclusions
This study provided the evidence for presence of toxigenic
C. difficle (toxinotype V) in the outlet of a WWTP in Iran.
A combination of slpA sequence typing, tcdC genotyping and
toxinotyping indicated that the C. difficile isolate may closely
be related to RT078. Existence of a MDR and Tn916-like
carrying-isolate of C. difficile in the outlet raises a question
about the efficacy of wastewater treatment process. It should
be noted that the discharge of outlet wastewater to environ-
ment can result in dissemination ofC. difficile in settings other
than hospitals and consequently may lead to CA-CDI in hu-
man populations and animals.
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